The global hematologic disorders testing sector is exhibiting significant growth, propelled by a rising incidence of lymphoma and other related illnesses. Experts estimate the present market scope to be substantial, with projections indicating a steady compound annual increase rate (CAGR) over the coming period. Key drivers shaping the industry inc